NuSkin Enterprises NUS Goodwill impairment
Goodwill impairment at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by NuSkin Enterprises in its filing.
Tagged under the XBRL concept us-gaap:GoodwillImpairmentLoss.
The source filing: NuSkin Enterprises’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-032055
During the three months ended June 30, 2026, the Company determined that the continued decline in the Company’s stock price and corresponding market capitalization as well as declines in the manufacturing segment forecast was a triggering event that required the Company to perform a quantitative impairment analysis. Based on the analysis, the Company concluded the fair value of the manufacturing reporting unit was less than the carrying value. As a result, the Company recorded a non-cash goodwill impairment charge of $78.9 million within impairment expenses on the consolidated statement of income. As part of the Company’s impairment analysis, the fair value of the reporting unit was determined using the income and market approach. The income approach used level 3 inputs and utilized management’s estimates related to future cash flows, which assumed factors such as revenue growth rates, profitability margins, and discount rates.
Item 1. Financial Statements (Unaudited):
FAQ
- What is NuSkin Enterprises's goodwill impairment?
- NuSkin Enterprises (NUS) reported goodwill impairment of $78.9M in Q2 2026.
- What does goodwill impairment mean?
- Write-down of goodwill carrying value when a reporting unit's fair value falls below its book value, indicating that past acquisitions have lost value.
Ask your AI about NuSkin Enterprises's goodwill impairment.
Connect your AI assistant and compare it to peers, right in your chat.
